Ability Biologics today announces the final closing of its #seedfunding, raising a total of US$ 18 million. More about this financing and Ability's vision to generate novel, highly targeted immunomodulators on ability.bio Ability Biologics annonce aujourd'hui la clôture de son financement de démarrage de 18 millions $ US pour la génération de nouveaux immunomodulateurs hautement ciblés. ability.bio
Ability Biologics
Biotechnology Research
Montreal, Quebec 1,033 followers
Developing innovative targeted immuno therapeutics to addressing unmet medical needs for cancer and autoimmune diseases
About us
Our Mission: Develop innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases. The premier biotherapeutic targeting company Our powerful AbiLeap™ discovery engine combines massively parallel, continuously learning AI with an extensive database of antigen-antibody interactions to generate fully human, IgG-based multispecific antibodies of exquisite selectivity and affinity. The antibodies respond to environmental signals within the cellular microenvironment, generating logic-gated therapeutics. We are dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need.
- Website
-
https://ability.bio
External link for Ability Biologics
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Montreal, Quebec
- Type
- Privately Held
- Founded
- 2023
- Specialties
- biotherapeutics, AI/ML, and antibodies
Locations
-
Primary
3 Place Ville-Marie
Montreal, Quebec H3B 2E3, CA
Employees at Ability Biologics
Updates
-
SAVE THE DATE: Dr. Jean-Philippe Buerckert VP Technology at Ability Biologics will attend the Gordon Research Conferences on #Antibody Biology & Engineering to be held March 17-22 in Lucca, Italy.
-
We're excited to share our new job opportunity with you! If you looking to join a dynamic and growing team focused on delivering tomorrow’s best in class antibody therapeutics in oncology and immunology, click the link below: ___________________ Nous sommes ravis de vous partager une nouvelle opportunité d'emploi au sein de notre équipe! Si vous souhaitez rejoindre une équipe dynamique et en pleine croissance qui se consacre à la mise au point des meilleurs anticorps thérapeutiques de demain dans les domaines de l'oncologie et de l'immunologie, cliquez sur le lien ci-dessous : https://lnkd.in/gtejqFak
-
We're excited to share our new job opportunity with you! If you looking to join a dynamic and growing team focused on delivering tomorrow’s best in class antibody therapeutics in oncology and immunology, click the link below: ___________________ Nous sommes ravis de vous partager une nouvelle opportunité d'emploi au sein de notre équipe! Si vous souhaitez rejoindre une équipe dynamique et en pleine croissance qui se consacre à la mise au point des meilleurs anticorps thérapeutiques de demain dans les domaines de l'oncologie et de l'immunologie, cliquez sur le lien ci-dessous : https://lnkd.in/gmxtKieh
-
Press Release 6 December 2023 Ability Biologics Unveils Discovery Platform that Generates Antibodies with Unparalleled Specificity and Selectivity Company emerges from stealth with the closing of $12 million seed funding https://lnkd.in/e3VjSqTf
Microsoft Word - Ability Seed Round PR English for release 20231206
ability.bio